Related Experiment Video
Updated: Sep 26, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Aspiration pneumonia. Recognizing and managing a potentially growing disorder
John L Johnson1, Christina S Hirsch
1Division of Infectious Diseases, Case Western Reserve University School of Medicine, Room E-202, Tuberculosis Research Unit, 10900 Euclid Ave, Cleveland, OH 44106-4984, USA. jlj@po.cwru.edu
Abstract:
Gross aspiration of liquid or particulate matter into the lung can result in severe hypoxemia, pulmonary infiltrates in dependent lung regions, fever, and leukocytosis. The initial lung injury is primarily due to inflammatory mediators rather than infection. The responsible bacterial pathogens differ between community-acquired and nosocomial aspiration pneumonia. Many aspiration pneumonias are mixed aerobic-anaerobic infections. Enteric gram-negative bacilli and S aureus are more common in nosocomial aspiration pneumonia. Current treatment guidelines support initial empirical antibiotic therapy in patients with severe aspiration pneumonia pending culture results. Appropriate initial treatment improves outcome. Antimicrobial therapy for aspiration pneumonia is often empirical and should be based on patient characteristics, the setting in which aspiration occurred, the severity of pneumonia, and available information regarding local pathogens and resistance patterns.
Insights
Aspiration pneumonia causes severe lung injury, often from inflammation, not just infection. Early, targeted antibiotic treatment based on patient factors and local resistance patterns is crucial for better outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Critical Care Medicine
Background:
- Aspiration of foreign material into the lungs can lead to severe pneumonia.
- Initial lung injury is often mediated by inflammation, with infection playing a secondary role.
- Pathogen profiles vary significantly between community-acquired and hospital-acquired (nosocomial) aspiration pneumonia.
Purpose of the Study:
- To summarize the understanding of aspiration pneumonia, including its pathophysiology, causative agents, and management.
- To highlight the importance of empirical antibiotic therapy in severe cases.
- To emphasize tailoring antimicrobial treatment to specific patient and local epidemiological factors.
Main Methods:
- Review of current literature and treatment guidelines for aspiration pneumonia.
- Analysis of differences in bacterial pathogens based on acquisition setting (community vs. nosocomial).
- Discussion of the role of inflammatory mediators in initial lung injury.
Main Results:
- Aspiration pneumonia can cause hypoxemia, pulmonary infiltrates, fever, and leukocytosis.
- Mixed aerobic-anaerobic infections are common.
- Nosocomial aspiration pneumonia frequently involves enteric gram-negative bacilli and Staphylococcus aureus.
Conclusions:
- Prompt and appropriate empirical antibiotic therapy is vital for improving outcomes in severe aspiration pneumonia.
- Treatment decisions should consider patient characteristics, the context of aspiration, pneumonia severity, and local resistance data.
- Understanding the distinct microbial patterns in different settings is key to effective management.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology